Crossmark

Surface-modified lipid-based nanocarriers as a pivotal delivery approach for cancer therapy: application and recent advances in targeted cancer treatment‏

Crossref DOI link: https://doi.org/10.1186/s43088-024-00566-x

Published Online: 2024-10-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Anwar, Doaa M.

Hedeya, Heidy Y.

Ghozlan, Sama H.

Ewas, Basma M.

Khattab, Sherine N. https://orcid.org/0000-0002-3162-6386
License Information

Text and Data Mining valid from 2024-10-23

Version of Record valid from 2024-10-23
More Information

Article History

Received: 18 April 2024

Accepted: 4 October 2024

First Online: 23 October 2024

Declarations

:

: Not applicable.

: Not applicable.

: Authors declared that there is no conflict of interest.

Document is current

Any future updates will be listed below